Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 216 (TMEM216) is an integral membrane protein that is part of the tectonic-like complex required for tissue-specific ciliogenesis, likely regulating ciliary membrane composition and involved in the maintenance and development of cilia in various tissues. Mutations in TMEM216 can cause ciliopathies including Joubert syndrome type 2 and Meckel syndrome type 2, disorders characterized by developmental and neurological defects. This gene has no established role as a therapeutic target, nor are there known direct pharmacological modulators or biomarkers currently used in clinical practice.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 216 (TMEM216).